Articles

Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome

Department of Hematology, Oncology, and Stem Cell Transplantation, Faculty of Medicine and Medical Center, University of Freiburg, Germany
Clinical Trials Unit, Faculty of Medicine and Medical Center, University of Freiburg, Germany
EORTC Headquarters, Brussels, Belgium
Department of Hematology, Oncology, and Stem Cell Transplantation, Faculty of Medicine and Medical Center, University of Freiburg, Germany;Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA
Department of Hematology, Oncology, and Stem Cell Transplantation, Faculty of Medicine and Medical Center, University of Freiburg, Germany
Department of Hematology, Haga Hospital, The Hague, the Netherlands
DKFZ Heidelberg, Division of Epigenomics and Cancer Risk Factors, Heidelberg, Germany;German Cancer Research Consortium (DKTK), Heidelberg, Germany
DKFZ Heidelberg, Division of Epigenomics and Cancer Risk Factors, Heidelberg, Germany
Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine and Medical Center, University of Freiburg, Germany
Department of Hematology, Oncology, and Stem Cell Transplantation, Faculty of Medicine and Medical Center, University of Freiburg, Germany;Department of Internal Medicine II, Hematology/Oncology, Augsburg Medical Center, Germany
Department of Hematology, Oncology, and Stem Cell Transplantation, Faculty of Medicine and Medical Center, University of Freiburg, Germany;German Cancer Research Consortium (DKTK), Freiburg, Germany
Vol. 104 No. 1 (2019): January, 2019 https://doi.org/10.3324/haematol.2017.187278